Stocks
Allogene Therapeutics (ALLO) FCF US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| FCF, bln rub | ? | -188.1 | -181.1 | -206.3 | -225.7 | -239.2 | -217.9 | ||
| Changes by years, y/y, % | +293% | -4% | +14% | +9% | +6% | +38.0% | |||
Allogene Therapeutics. FCF, bln rub
Allogene Therapeutics. FCF, changes, %
Allogene Therapeutics. FCF, sum by quarters, bln rub
Allogene Therapeutics (ALLO) FCF US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| FCF, bln rub | ? | -55.5 | -53.9 | -55.9 | -63.6 | -44.5 | -217.9 | |
| Changes by years, y/y, % | +16% | -16% | -17% | +2% | -20% | |||
| Changes by quarters, q/q, % | -11% | -3% | +4% | +14% | -30% | |||
